» Articles » PMID: 38760869

Platelet-rich Plasma (PRP) Treatment of the Ovaries Significantly Improves Fertility Parameters and Reproductive Outcomes in Diminished Ovarian Reserve Patients: a Systematic Review and Meta-analysis

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The incidence of infertility caused by diminished ovarian reserve has become a significant problem worldwide. The beneficial effect of PRP treatment of the ovaries has already been described, but the high-level evidence of its effectiveness has not yet been proven.

Materials And Methods: A systematic search was performed in five databases, until March 12th, 2024. Both randomized and non-randomized studies that compared PRP treatment of the ovaries to self-control among women with diminished ovarian reserve were eligible for inclusion. Hormonal levels (Anti-Müllerian hormone (AMH), Follicle stimulating hormone (FSH), Luteinizing hormone (LH), Estradiol (E2), In-vitro fertilization parameters (Antral follicle count, oocyte, and embryo count), biochemical and spontaneous pregnancy and livebirth were measured.

Results: 38 eligible studies were identified reporting on 2256 women. The level of AMH rised, the level of FSH decreased significantly after the PRP treatment. AMH 1 month MD 0.20 (n = 856, p > 0.001, 95% CI: [0.12;0.28]), 2 months MD 0.26 (n = 910, p = 0.013, 95% CI: [0.07;0.44]), 3 months MD 0.36 (n = 881, p = 0.002,95% CI: [0.20;0.52]). FSH 1 month MD -10.20 (n = 796, p > 0.039, 95% CI: [-19.80;-0.61]), 2 months MD -7.02 (n = 910, p = 0.017, 95% CI: [-12.48; -1.57]), 3 months MD -8.87 (n = 809, p = 0.010, 95% CI: [-14.19; -3.55]). The antral follicle count elevated significantly MD 1.60 (n = 1418, p =  < 0.001, 95% CI: [0.92; 2.27]). Significant improvement was observed in the number of retrieved oocytes MD 0.81 (n = 802, p = 0.002, 95% CI: [0.36; 1.26]), and embryos created MD 0.91 (n = 616, p = 0.001, 95% CI: [0.45;1.36]). The incidence of spontaneous pregnancy following PRP treatment showed a rate with a proportion of 0.07 (n = 1370, 95% CI: 0.04-0.12), the rate of biochemical pregnancy was 0.18 (n = 1800, 95% CI: 0.15-0.22), livebirth was 0.11 (n = 1482, 95% CI: 0.07-0.15).

Conclusions: Our meta-analysis showed that based on protocolized analysis of the widest scientific literature search to date, containing predominantly observational studies, PRP treatment resulted in a statistically significant improvement in the main fertility parameters of diminished ovarian reserve women. Further multicenter, randomized trials, with large patient numbers and a longer follow-up period are needed to certify our results and develop the most effective treatment protocol.

Citing Articles

Platelet-Rich Plasma and Electrochemical Biosensors: A Novel Approach to Ovarian Function Evaluation and Diagnostics.

Ivaskiene T, Kaspute G, Bareikiene E, Prentice U Int J Mol Sci. 2025; 26(5).

PMID: 40076937 PMC: 11899975. DOI: 10.3390/ijms26052317.


A Retrospective Cohort Study Investigating the Effect of Intraovarian Platelet-Rich Plasma Therapy on the Oxidative State of Follicular Fluid in Women with Diminished Ovarian Reserve.

Mazloomi S, Tayebinia H, Farimani M, Ghorbani M Chonnam Med J. 2025; 61(1):46-51.

PMID: 39958271 PMC: 11821988. DOI: 10.4068/cmj.2025.61.1.46.


The role of platelet-rich plasma in biomedicine: A comprehensive overview.

Zhang Z, Liu P, Xue X, Zhang Z, Wang L, Jiang Y iScience. 2025; 28(2):111705.

PMID: 39898035 PMC: 11787504. DOI: 10.1016/j.isci.2024.111705.

References
1.
Shrivastava J, More A, Shrivastava V, Choudhary N, Shrivastava D . Enhancement of Ovarian Reserve and Oocyte Quality After Platelet-Rich Plasma Instillation in a Woman With Diminished Anti-Müllerian Hormone. Cureus. 2024; 16(2):e53474. PMC: 10910621. DOI: 10.7759/cureus.53474. View

2.
Garavelas A, Mallis P, Michalopoulos E, Nikitos E . Clinical Benefit of Autologous Platelet-Rich Plasma Infusion in Ovarian Function Rejuvenation: Evidence from a Before-After Prospective Pilot Study. Medicines (Basel). 2023; 10(3). PMC: 10056078. DOI: 10.3390/medicines10030019. View

3.
Scott Sills E, Wood S . Autologous activated platelet-rich plasma injection into adult human ovary tissue: molecular mechanism, analysis, and discussion of reproductive response. Biosci Rep. 2019; 39(6). PMC: 6549090. DOI: 10.1042/BSR20190805. View

4.
Hosseinisadat R, Saeed L, Ghasemirad A, Habibzadeh V, Safar Heidari S . Assessment of the effect of serum and follicular fluid vitamin D and glucose on assisted reproductive technique outcome: A cross-sectional study. Int J Reprod Biomed. 2022; 20(3):221-230. PMC: 9099362. DOI: 10.18502/ijrm.v20i3.10714. View

5.
Cakiroglu Y, Saltik A, Yuceturk A, Karaosmanoglu O, Yildirim Kopuk S, Scott R . Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency. Aging (Albany NY). 2020; 12(11):10211-10222. PMC: 7346073. DOI: 10.18632/aging.103403. View